Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States

31 Aug 2022

Abstract excerpt

BACKGROUND: Data on the effectiveness and safety of dolutegravir-based antiretroviral therapy (ART) for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy as compared with other ART regimens commonly used in the United States and Europe, particularly when initiated before conception, are limited. METHODS: We conducted a study involving pregnancies in persons with HIV-1 infection in the Pediatric...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36053505
DOI: 10.1056/nejmoa2200600

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United StatesPMID 36053505Read ↗

Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIVSemantic proximity Read ↗

HIV-1 Integrase Strand Transfer Inhibitors and NeurodevelopmentSemantic proximity Read ↗

Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels.Semantic proximity Read ↗

An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocolSemantic proximity Read ↗

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defectsSemantic proximity Read ↗

Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational ageSemantic proximity Read ↗

Metabolic implications and safety of dolutegravir use in pregnancySemantic proximity Read ↗

Association between maternal human immunodeficiency virus infection and preterm birthSemantic proximity Read ↗

Trends in Pregnancy Rates Among Women With Human Immunodeficiency VirusSemantic proximity Read ↗

Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.Semantic proximity Read ↗

Preterm birth among women with HIV: impact of preconception cART initiationSemantic proximity Read ↗

Pregnancy in women living with perinatally acquired HIV: Perinatal outcomes and drug resistance profile.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.